Trial Profile

Clinical study for JS016 in USA

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 14 Jul 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Etesevimab (Primary)
Indications COVID 2019 infections
Focus Adverse reactions; Pharmacokinetics

Most Recent Events

12 Jul 2020 According to an Junshi Biosciences media release, the company has entered this study during the second quarter.
12 Jul 2020 Status changed from planning to recruiting, according to an Junshi Biosciences media release.
08 Jun 2020 According to an Eli Lilly and Company media release, this study will begin dosing in coming days.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com